EDEM3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.801600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.718800E-01
Normal-vs-Stage2
2.460600E-01
Normal-vs-Stage3
6.287200E-01
Normal-vs-Stage4
1.885410E-01
Stage1-vs-Stage2
1.746020E-01
Stage1-vs-Stage3
8.331900E-02
Stage1-vs-Stage4
7.032200E-01
Stage2-vs-Stage3
1.027020E-01
Stage2-vs-Stage4
3.625800E-01
Stage3-vs-Stage4
1.464970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.050800E-01
Normal-vs-AfricanAmerican
8.867600E-02
Normal-vs-Asian
2.853800E-01
Caucasian-vs-AfricanAmerican
3.193200E-01
Caucasian-vs-Asian
4.774800E-01
AfricanAmerican-vs-Asian
7.426400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.401800E-01
Normal-vs-Female
3.366600E-01
Male-vs-Female
3.138200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.187200E-01
Normal-vs-Age(41-60Yrs)
2.855800E-01
Normal-vs-Age(61-80Yrs)
2.634400E-01
Normal-vs-Age(81-100Yrs)
4.328200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.150600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.520400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.248000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.323000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.798000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.932800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.230600E-01
Normal-vs-Daily Drinker
8.171000E-01
Normal-vs-Weekly Drinker
3.497000E-01
Normal-vs-Occasional Drinker
1.749850E-01
Normal-vs-Social Drinker
2.253400E-01
Non Drinker-vs-Daily Drinker
7.697700E-02
Non Drinker-vs-Weekly Drinker
8.714000E-01
Non Drinker-vs-Occasional Drinker
8.645400E-01
Non Drinker-vs-Social Drinker
6.445800E-01
Daily Drinker-vs-Weekly Drinker
1.124990E-01
Daily Drinker-vs-Occasional Drinker
4.655800E-02
Daily Drinker-vs-Social Drinker
4.494200E-02
Weekly Drinker-vs-Occasional Drinker
9.810400E-01
Weekly Drinker-vs-Social Drinker
8.162000E-01
Occasional Drinker-vs-Social Drinker
7.442000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.179610E-01
Normal-vs-Grade 2
2.774200E-02
Normal-vs-Grade 3
6.561800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.677200E-01
Grade 1-vs-Grade 3
2.641000E-01
Grade 1-vs-Grade 4
1.179610E-01
Grade 2-vs-Grade 3
5.499600E-01
Grade 2-vs-Grade 4
2.774200E-02
Grade 3-vs-Grade 4
6.561800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.828400E-01
Normal-vs-NonDiabetic
3.089200E-01
Diabetic-vs-NonDiabetic
3.877600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.937400E-01
Normal-vs-NoPancreatitis
3.106800E-01
Pancreatitis-vs-NoPancreatitis
4.643400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.665400E-01
Normal-vs-N1
2.793600E-01
N0-vs-N1
2.723400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.885000E-01
Normal-vs-TP53-NonMutant
1.874360E-01
TP53-Mutant-vs-TP53-NonMutant
7.019200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
